72
decrease their threshold for seizures; this does not appear to be a problem when intakes are within recommended
amounts.
Acesulfame-K
Because acesulfame potassium (acesulfame-K) passes through the body unchanged, it does not provide any energy
nor does it increase the intake of potassium. Acesulfame-K is approved for use in the United States, Canada, and
more than 60 other countries.
Sucralose
Tagatose
The FDA granted the fructose relative tagatose the status of “generally recognized as safe,” making it available as a
low-kcalorie sweetener for a variety of foods and beverages. This monosaccharide is naturally found in only a few
foods, but it can be derived from lactose. Unlike fructose or lactose, however, 80 percent of tagatose remains
Alitame and Cyclamate
FDA approval for alitame and cyclamate is still pending. To date, no safety issues have been raised for alitame, and
it has been approved for use in other countries. In contrast, cyclamate has been battling safety issues for 50 years.
Approved by the FDA in 1949, cyclamate was banned in 1969 principally on the basis of one study indicating that it
caused bladder cancer in rats.
The National Research Council has reviewed dozens of studies on cyclamate and concluded that neither cyclamate
nor its metabolites cause cancer. The council did, however, recommend further research to determine if heavy or
long-term use poses risks. Although cyclamate does not initiate cancer, it may promote cancer development once it
is started. The FDA currently has no policy on substances that enhance the cancer-causing activities of other
substances, but it is unlikely to approve cyclamate soon, if at all. Agencies in more than 50 other countries,
including Canada, have approved cyclamate.
Acceptable Daily Intake